Collegium Pharmaceutical, Inc. Stock Analysis & AI Score
Collegium Pharmaceutical, Inc. (COLL) has an ST Score of 44.8 (C+), driven by its Profitability (A) and held back by its Momentum (D-). Analysts rate it Buy with a $48.00 price target (+112.0% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Collegium Pharmaceutical, Inc. (COLL) has an ST Score of 44.8 (C+), driven by its Profitability (A) and held back by its Momentum (D-). Analysts rate it Buy with a $48.00 price target (+112.0% upside).
- Strongest
- ProfitabilityA
- Weakest
- MomentumD-
All factor grades
- ProfitabilityA
- ForecastA
- ValuationC-
- GrowthC-
- Financial StrengthD-
- MomentumD-
- Piotroski5/9
Contact
COLL stock: frequently asked questions
What is COLL's ST Score?
Collegium Pharmaceutical, Inc. (COLL) has an ST Score of 44.8 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is COLL a buy, hold, or sell?
Analysts rate COLL a Buy, with a price target of $48.00 (+112.0% vs the current price). Our ST Score grades it C+ (44.8/100). The ST Score is a data-driven signal, not a recommendation.
What are COLL's factor grades?
Valuation C-, Profitability A, Financial Strength D-, Momentum D-, Growth C-, Forecast A.
What is COLL's valuation grade?
Collegium Pharmaceutical, Inc. (COLL) earns a valuation grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is COLL's growth grade?
Collegium Pharmaceutical, Inc. (COLL) earns a growth grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is COLL's profitability grade?
Collegium Pharmaceutical, Inc. (COLL) earns a profitability grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is COLL's financial strength grade?
Collegium Pharmaceutical, Inc. (COLL) earns a financial strength grade of D-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for COLL?
The average analyst price target for Collegium Pharmaceutical, Inc. (COLL) is $48.00 from 12 analysts, which is +112.0% versus the recent price of $22.64.
What is COLL's Piotroski score?
Collegium Pharmaceutical, Inc. (COLL) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.